Navigation Links
New discovery may lead to new class of allergy drugs
Date:1/29/2009

The insights from this work on the unexpected role of eotaxin should provide novel therapeutic opportunities for intervention during diseases like asthma, food allergies and other situations where unchecked allergic responses cause problems."

According to the U.S. Centers for Disease Control and Prevention Allergies, more than 50 million Americans suffer from allergies each year. Allergies are the 6th leading cause of chronic illness in the U.S., costing more than $18 billion. The most severe type of allergic reaction is called "anaphylaxis," which can be fatal.


'/>"/>

Contact: Cody Mooneyhan
cmooneyhan@faseb.org
301-634-7104
Federation of American Societies for Experimental Biology
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Discovery could lead to a new animal model for hepatitis C
2. Billion-year revision of plant evolution timeline may stem from discovery of lignin in seaweed
3. Cancer-causing gene discovery suggests new therapies
4. Jumbo-sized discovery made in Malaysia
5. UC Davis discovery offers hope for treating kidney cancer
6. Life Sciences Discovery Fund awards health research program grants
7. In just 5 years, gene discovery to clinical trial of potential treatment
8. Discovery of new gene associated with diabetes risk suggests link with body clock
9. Kidney function discovery sheds light on genetic complexity of disease
10. New discovery may enhance MRI scans, lead to portable MRI machines
11. Discovery of giant roaming deep sea protist provides new perspective on animal evolution

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... of lower early bird registration rates and regist...ss of 2010 at http://www.iofwco-ecceo10.org/ ,... International Osteoporosis Foundation (IOF) and t...cts of Osteoporosis and Osteoarthritis (ESCEO). Mo...re expected to attend. The exciting scientific pro...
(Date:11/30/2009)..., VILNIUS, Lithuania, Nov. 30 Neu... provider of high-precision biometric identificati...the company,s core product line: VeriLook 4.0 So...n and MegaMatcher 3.1 SDK for large-scale multi-... systems (AFIS). Expanded capabilities in VeriLook...
(Date:11/26/2009)...e at last worked out a way of using recordings of ...pulations. This is the first time sound recordings... accurate estimates of bird species, populations. ... Ecological Society,s Journal of Applied Ecology ... a major advance in our ability to monitor whale a...
Breaking Biology News(10 mins):New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 2New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 3Ecologists sound out new solution for monitoring cryptic species 2Steven Holtzman Joins Satori Pharmaceuticals Board of Directors 56134 1Steven Holtzman Joins Satori Pharmaceuticals Board of Directors 56134 2Steven Holtzman Joins Satori Pharmaceuticals Board of Directors 56134 3Steven Holtzman Joins Satori Pharmaceuticals Board of Directors 56134 4Encap agrees colonic drug delivery licensing deal 9775 1Encap agrees colonic drug delivery licensing deal 9775 2Encap agrees colonic drug delivery licensing deal 9775 3Sinovac Obtains Production License for H1N1 Vaccine 13826 1Sinovac Obtains Production License for H1N1 Vaccine 13826 2Sinovac Obtains Production License for H1N1 Vaccine 13826 3
...ntal enrichment and increased social stress can bo...ing to new monkey research at Wake Forest Universi... shown that social rank whether animals are domin... affect the amount of cocaine that monkeys will se...molgus monkeys will invariably stratify by social ...
...hers report today in the journal Nature Genetics t...s can be associated with a dramatically lower risk...population. , The insight that rare mutations may... of common yet complex diseases such as hypertensi...atment of diseases such as diabetes and schizophre...
...esperately try to reach for a break in the canopy ...ffliction: Shade avoidance syndrome or SAS. Now, t...ight by researchers at the Salk Institute for Biol... shade, plants switch on a natural chemical factor...xin that lets a plant grow and ultimately stretch ...
Other Biology News:Environmental enrichment can reduce cocaine use, researchers find 2Yale study shows how rare genes have big impact on blood pressure 2A place in the sun 2A place in the sun 3
(Date:11/30/2009)...G OF PRUSSIA, Pa., Nov. 30 Cadien...zing in interactive marketing services and soluti...he launch of its HATCH Consulting services g...ng strategic experts across a range of emerging ar...nsulting team is committed to guiding companies an...
(Date:11/30/2009)...CLIFF MANOR, N.Y., Nov. 30 Good Pu...nt for the publication of company-sponsored medica... British Medical Journal (BMJ). "The publication o...nce of providing support and guidance for industry...esults in the peer-reviewed medical literature," s...
(Date:11/30/2009)... Md., Nov. 30 Novavax, I...ted enrollment in the Phase II clinical study of i...nded strains) VLP vaccine candidate in healthy adu... randomized, double-blind, active-controlled study...enicity of two different doses (15 mcg and 60 mcg)...
(Date:11/30/2009)...d COPENHAGEN, Nov. 30 Exiqon A/S (... the Harvard Medical School ICCB-Longwood Screenin...RNA Screening Center of Excellence. ICCB-L suppor...sociated hospitals and institutions, for high-thro...ies. ,, MicroRNAs are a novel class of small, n...
Breaking Biology Technology:Cadient Interactive Announces the Launch of HATCH Consulting Services 2Cadient Interactive Announces the Launch of HATCH Consulting Services 3ISMPP Announces Publication of Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP2 Guidelines Published in the BMJ 2ISMPP Announces Publication of Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP2 Guidelines Published in the BMJ 3NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 3NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 4Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3
...X: ARPN) today announced that the European Medicin...ting Authorisation Application (MAA) for,intraveno...nous iclaprim in,the European Union for the treatm... (cSSTI). Iclaprim is a hospital antibiotic drug c...ty against MRSA and an extended range,of important...
...s 27th annual Inc. 500 ranking of the fastest-grow...rmation Technology (IT) services provider,MicroTec...th of 1078.5%., The 2008 Inc. 500 list measures r...companies had to be U.S.-based, privately held, in...companies - and have had at least,$200,000 in net ...
...ems,(MMS) today announced a new partnership with t...e result of a legislative initiative that,establis...enefit for North,Dakota state employees and other ... Pharmaceutical Care System(TM) will provide North...ing and technology to guide and,document the deliv...
Other Biology Technology:Arpida's iclaprim MAA Accepted for Review by EMEA 2Arpida's iclaprim MAA Accepted for Review by EMEA 3MicroTech Ranks No. 285 on Inc. Magazine's 2008 List of the 500 Fastest Growing Private Companies in America 2North Dakota Pharmacists and Medication Management Systems Partner to Deliver Quality MTM Services to Patients With Diabetes 2
Goat Anti-Zebrafish Ephrin-B2 Polyclonal Antibody, Biotin Conjugated from R&D Systems
PhotoMan Direct Copy Hood and UV Shield set, 10 x 12 cm from Hoefer, Inc.
Donor Goat Serum from Lifeblood Medical, Inc.
GeneRacer Kit with SuperScript II RT and Zero Blunt TOPO PCR Cloning kit for Sequencing from Invitrogen
Biology Products: